rs11857410

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022369.4(STRA6):​c.331C>T​(p.Leu111Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.185 in 1,613,882 control chromosomes in the GnomAD database, including 31,538 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2096 hom., cov: 32)
Exomes 𝑓: 0.19 ( 29442 hom. )

Consequence

STRA6
NM_022369.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.19

Publications

14 publications found
Variant links:
Genes affected
STRA6 (HGNC:30650): (signaling receptor and transporter of retinol STRA6) The protein encoded by this gene is a membrane protein involved in the metabolism of retinol. The encoded protein acts as a receptor for retinol/retinol binding protein complexes. This protein removes the retinol from the complex and transports it across the cell membrane. Defects in this gene are a cause of syndromic microphthalmia type 9 (MCOPS9). Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
STRA6 Gene-Disease associations (from GenCC):
  • Matthew-Wood syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • microphthalmia, isolated, with coloboma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 15-74196083-G-A is Benign according to our data. Variant chr15-74196083-G-A is described in ClinVar as Benign. ClinVar VariationId is 317117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRA6NM_022369.4 linkc.331C>T p.Leu111Leu synonymous_variant Exon 5 of 19 ENST00000395105.9 NP_071764.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRA6ENST00000395105.9 linkc.331C>T p.Leu111Leu synonymous_variant Exon 5 of 19 1 NM_022369.4 ENSP00000378537.4

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22151
AN:
152026
Hom.:
2096
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0624
Gnomad AMI
AF:
0.135
Gnomad AMR
AF:
0.0878
Gnomad ASJ
AF:
0.187
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0323
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.120
GnomAD2 exomes
AF:
0.145
AC:
36275
AN:
250618
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.0614
Gnomad AMR exome
AF:
0.0655
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.256
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.189
AC:
276193
AN:
1461738
Hom.:
29442
Cov.:
33
AF XY:
0.185
AC XY:
134226
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.0534
AC:
1787
AN:
33478
American (AMR)
AF:
0.0669
AC:
2993
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.185
AC:
4841
AN:
26134
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.0472
AC:
4074
AN:
86252
European-Finnish (FIN)
AF:
0.264
AC:
14066
AN:
53334
Middle Eastern (MID)
AF:
0.0512
AC:
295
AN:
5766
European-Non Finnish (NFE)
AF:
0.214
AC:
237850
AN:
1111968
Other (OTH)
AF:
0.170
AC:
10276
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
14153
28306
42459
56612
70765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7994
15988
23982
31976
39970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.146
AC:
22147
AN:
152144
Hom.:
2096
Cov.:
32
AF XY:
0.143
AC XY:
10654
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0622
AC:
2583
AN:
41520
American (AMR)
AF:
0.0877
AC:
1341
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.187
AC:
650
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5182
South Asian (SAS)
AF:
0.0317
AC:
153
AN:
4822
European-Finnish (FIN)
AF:
0.258
AC:
2733
AN:
10590
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14289
AN:
67952
Other (OTH)
AF:
0.118
AC:
250
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
921
1842
2763
3684
4605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.177
Hom.:
8883
Bravo
AF:
0.129
Asia WGS
AF:
0.0270
AC:
92
AN:
3478
EpiCase
AF:
0.186
EpiControl
AF:
0.182

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Matthew-Wood syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.9
DANN
Benign
0.74
PhyloP100
3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11857410; hg19: chr15-74488424; COSMIC: COSV60584425; COSMIC: COSV60584425; API